GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference

GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference

TORONTO, May 21, 2013 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN)
("GeneNews") announced today that its President and Chief Operating Officer,
Gailina J. Liew, will present an update on the Company's business at the 2nd
Annual Bloom Burton & Co. Healthcare Investor Conference on Wednesday, May 22,
2013 at 2:30 PM ET. The conference will be held at the Toronto Board of Trade
in Toronto, ON.

About the Bloom Burton & Co. Healthcare Investor Conference

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S.,
Canadian and international investors who are interested in the latest
developments in the Canadian healthcare sector. Attendees will have an
opportunity to obtain corporate updates from the premier Canadian publicly
traded and private companies through presentations and private meetings.

About GeneNews

GeneNews is a molecular diagnostics company focused on developing and
commercializing proprietary blood-based diagnostic tests through the
application of functional genomics to enable early diagnosis and personalized
health management. The Company has developed a patented core platform
technology, the Sentinel Principle^®, which has the power to detect and stage
virtually any disease or medical condition from a simple blood sample.
GeneNews has applied the Sentinel Principle^® in major areas with unmet
clinical needs such as cancer, arthritis, cardiovascular disease and
neurological disorders. GeneNews' lead product, ColonSentry^®, is the world's
first blood test to assess an individual's current risk for colorectal cancer.
For more information on GeneNews and ColonSentry^®, go to www.GeneNews.com or
www.ColonSentry.com.

Forward-Looking Statements

This press release contains forward-looking statements, which reflect the
Company's current expectations regarding future events. The forward-looking
statements involve risks and uncertainties. Actual events could differ
materially from those projected herein. Investors should consult the Company's
ongoing quarterly filings and annual reports for additional information on
risks and uncertainties relating to these forward-looking statements. The
reader is cautioned not to rely on these forward-looking statements. The
Company disclaims any obligation to update these forward-looking statements.

CONTACT: Company Contact:
         Gailina Liew
         President & COO
         Office: (905) 739-2036
         Mobile: (416) 844-0649
         gliew@genenews.com
        
         Investor & Media Contact:
         Stephen Kilmer
         Kilmer Lucas Inc.
         Office: (212) 618-6347
         Mobile: (647) 872-4849
         stephen@kilmerlucas.com